Table 1 Demographic data for CF patients.
From: Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients
Patient | Genetics | Age | RSI score | PPI yes/no | Gastric Juice pH | FEV1 (% pred) | BMI | IV days /year | Long-term antibiotic |
|---|---|---|---|---|---|---|---|---|---|
CF-1 | F508del/F508del | 26 | 17 | Yes | 6 | 2.0L (52%) | 19.9 | 22 | Azith Inh Coli Inh Tob |
CF-2 | F508del/F508del | 27 | 20 | Yes | 2 | 1.7 (42%) | 23.2 | 70 | Azith Fluclox Inh coli |
CF-3 | F508del/F508del | 20 | 25 | Ranitidine | 3 | 0.8L (26%) | 19.5 | 28 | Azith Fluclox Inh Coli |
CF-4 | F508del/F508del | 24 | 36 | Yes | 6 | 0.76L (28%) | 19 | 154 | Azith Inh Coli |
CF-5 | F508del/F508del | 41 | NA [died] | Yes | 5.5 | 0.45L (18%) | 18.2 | 65 | Azith Inh Tob |
CF-6 | F508del/F508del | 31 | 16 | Yes | 6 | 0.5L (12%) | 19.1 | 70 | Azith Inh Coli |
CF-7 | F508del/ R117H | 22 | 16 | Yes | 3 | 2.7L (66%) | 16.4 | 14 | Fluclox |
CF-8 | I507del/ Arg560Lys | 18 | 13 | Yes | 2 | 3.5L (88%) | 19.4 | 37 | Fluclox Inh Coli Inh Tob |
CF-9 | F508del/R117H | 30 | 14 | Yes | 6 | 1.55L (46%) | 17.8 | 56 | Fluclox Inh Coli |
CF-10 | F508del/F508del | 25 | 17 | Yes | 2 | 1.7L (38%) | 15.9 | 98 | Azith Fluclox Inh Tob |
CF-11 | F508del/G542X | 32 | NA [PEG removed] | No | 2 | 1.15L (36%) | 19.4 | 112 | Azith Inh Coli |
CF-12 | F508del/F508del | 30 | 19 | Yes | 6 | 1.2L (29%) | 19.8 | 115 | Azith Fluclox Inh Coli |
CF-13 | F508del/G542X | 24 | 15 | Yes | 2 | 1.65L (36%) | 15.24 | 197 | Azith Inh Coli Inh Tob |
CF-14 | F508del/ Arg851Ter | 23 | 22 | Yes | 6 | 2.3L (59%) | 20.2 | 56 | Azith |
CF-15 | G542X/G551D | 22 | NA [moved country] | Yes | 2 | 0.85L (28%) | 18 | 42 | Azith Inh Coli |
